Search


Current filters:

Start a new search
Add filters:

Use filters to refine the search results.


Results 1-10 of 18
Item hits:
Issue DateTitleAuthor(s)
15-Jul-2018Is peer review still anonymous?Ritchie, AI; Polkey, MI; Donaldson, GC; Wedzicha, JA
1-Sep-2018Asthma: upcoming themed issueWedzicha, JA; Martinez, FD
20-Jun-2018Indacaterol/glycopyrronium versus salmeterol/fluticasone in the prevention of clinically important deterioration in COPD: results from the FLAME studyAnzueto, AR; Kostikas, K; Mezzi, K; Shen, S; Larbig, M, et al
18-Dec-2018Human Rhinovirus Impairs the Innate Immune Response to Bacteria in Alveolar Macrophages in COPDFinney, LJ; Belchamber, KBR; Fenwick, PS; Kemp, SV; Edwards, MR, et al
18-Oct-2018Reply to: Different background, short duration, inappropriate participants may harm your conclusionChapman, KR; Hurst, JR; Fogel, RB; Pfister, P; Kostikas, K, et al
1-Oct-2018Childhood exposures, asthma, smoking, interactions and the catch-up hypothesisAllinson, JP; Hardy, R; Donaldson, GC; Wedzicha, JA; Royal Brompton & Harefield NHS Foundation Trust
1-Nov-2018The Phillip Morris Foundation for a smokefree world: a cause for concernGoldberg, DS; Lederer, DJ; MacKenzie, EJ; Moss, M; Samet, JM, et al
20-May-2018Long-term triple therapy de-escalation to indacaterol/glycopyrronium in COPD patients (SUNSET): a randomized, double-blind, triple-dummy clinical trialChapman, KR; Hurst, JR; Frent, S; Larbig, M; Fogel, R, et al
9-Aug-2018Single-inhaler triple versus dual therapy in patients with COPDWedzicha, JA; Banerji, D; Kostikas, K
10-Apr-2018Exacerbation heterogeneity in COPD: subgroup analyses from the FLAME studyVogelmeier, CF; Chapman, KR; Miravitlles, M; Roche, N; Vestbo, J, et al